Developmental and Epileptic Encephalopathy Due to a Novel ARHGEF9 Deletion Variant: Case Series of Two Siblings
Revista de Neurología · 26.05.2026 · 81 (5)
DOI: 10.31083/rn46598 ↗Kurz gefasst
Fallbericht in der Zeitschrift Revista de Neurología, online erschienen am 26.05.2026. Verfasst von Jie Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou Key Laboratory of Epilepsy Prevention and Resear…. Hauptthemen laut MEDLINE: Developmental Disabilities, Epilepsy, Rho Guanine Nucleotide Exchange Factors. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liuzhou Science and Technology Bureau, High-Level Talents Fund of Liuzhou People's Hospital affiliated to Guangxi Medical University.
Abstract (Originalsprache)
Introduction
Developmental and epileptic encephalopathy (DEE) is a group of severe neurological disorders characterized by early-onset epilepsy and developmental delay, often caused by genetic variants. Cdc42 Guanine Nucleotide Exchange Factor 9 (ARHGEF9) gene variants have been linked to DEE, yet novel variants and their phenotypic presentations remain incompletely characterized. Clinical Cases: Herein, we describe two siblings with DEE caused by a novel deletion variant in the ARHGEF9 gene. Both patients presented with early-onset epilepsy and developmental delay. Whole-exome sequencing identified a hemizygous c.1037_1045del variant in the ARHGEF9 gene (NM_015185.2) in both brothers, which is reported here for the first time. Notably, the two siblings exhibited a marked difference in outcomes: the elder brother achieved good seizure control with anti-epileptic drugs, while the proband, despite multidrug therapy and vagus nerve stimulation (VNS), exhibited a limited response and continued to experience frequent seizures.
Conclusions
These cases expand the genotypic spectrum of ARHGEF9-related disorders and underscore the intrafamilial phenotypic variability associated with this gene. These findings emphasize the significance of early genetic testing for establishing a diagnosis, assessing prognosis, and facilitating genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou Key Laboratory of Epilepsy Prevention and Research, 545000 Liuzhou, Guangxi, China.
Förderung
- Liuzhou Science and Technology Bureau
- High-Level Talents Fund of Liuzhou People's Hospital affiliated to Guangxi Medical University
Zitieren
APA
Li, J., Han, G., & Wei, Y. (2026). Developmental and Epileptic Encephalopathy Due to a Novel ARHGEF9 Deletion Variant: Case Series of Two Siblings. Revista de Neurología, 81(5). https://doi.org/10.31083/rn46598
Vancouver
Li J, Han G, Wei Y. Developmental and Epileptic Encephalopathy Due to a Novel ARHGEF9 Deletion Variant: Case Series of Two Siblings. Revista de Neurología. 2026;81(5). doi:10.31083/rn46598
BibTeX
@article{Li2026,
author = {Li, Jie and Han, Guangshun and Wei, Yizhi},
title = {Developmental and Epileptic Encephalopathy Due to a Novel ARHGEF9 Deletion Variant: Case Series of Two Siblings},
journal = {Revista de Neurología},
year = {2026},
volume = {81},
number = {5},
doi = {10.31083/rn46598}
}
EUVIMED